Oncimmune Holdings plc

ONC.L · LSE
Analyze with AI
8/31/2024
2/29/2024
8/31/2023
2/28/2023
Operating Activities
Net Income-£2-£1-£2-£4
Dep. & Amort.£0£0£0£1
Deferred Tax£0£0£0-£0
Stock-Based Comp.£0£0£0-£1
Change in WC£0-£0-£0£0
Other Non-Cash£1-£1-£1£2
Operating Cash Flow-£1-£2-£4-£3
Investing Activities
PP&E Inv.-£0-£0-£0-£0
Net Acquisitions£0£0£0-£0
Inv. Purchases£0£0£0£0
Inv. Sales/Matur.£0£0£0£0
Other Inv. Act.£1£0£11£1
Investing Cash Flow£1-£0£11£1
Financing Activities
Debt Repay.£0£0-£5£0
Stock Issued£0-£0-£0£2
Stock Repurch.£0£0£0£0
Dividends Paid£0£0£0£0
Other Fin. Act.-£0-£0-£0-£0
Financing Cash Flow-£0-£0-£5£2
Forex Effect£0£0£0-£1
Net Chg. in Cash£0-£2£2-£2
Supplemental Information
Beg. Cash£1£3£1£3
End Cash£1£1£3£1
Free Cash Flow-£1-£2-£4-£3
Oncimmune Holdings plc (ONC.L) Financial Statements & Key Stats | AlphaPilot